Amiliana Beatriz Pineda Fretez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Amiliana Beatriz Pineda Fretez has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Ana Zubeldía
Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Hospital de Clínicas. San Lorenzo, Paraguay
1 shared publication - Beatriz Soilan
Instituto Nacional de Enfermedades Respiratorias y del Ambiente. Asunción, Paraguay
1 shared publication - Betania Medina
Hospital Central Policial Rigoberto Caballero. Asunción, Paraguay
1 shared publication - Carolina Rojas
Ministerio de Salud Publica y Bienestar Social, Asunción, Paraguay
1 shared publication - Deili Nathalia Cuevas Casco
Sanatorio Italiano. Asunción, Paraguay
1 shared publication - Diana Verónica Paez Samaniego
Centro Médico Bautista. Asunción, Paraguay
1 shared publication
Latest Publications
- Open Access
- 30 April 2026
- Published by Sociedad Paraguaya de Pediatria in Pediatría (Asunción)
- Vol. 53 (1) , 5-14
Distribución de especies, serotipos y resistencia antimicrobiana de Shigella spp. en pacientes del área metropolitana de Paraguay (2019-2025)
Introduction: Shigellosis is an acute infection caused by bacteria of the genus Shigella, with high prevalence in pediatric populations. Surveillance allows the identification of serotypes and resistance patterns, improving clinical and epidemiological management. Objective: To determine the distribution of species, serotypes, and antimicrobial resistance of Shigella spp. in the metropolitan area of Paraguay (2019–2025). Methods: A cross-sectional descriptive observational study was conducted on 610 clinical bacterial isolates received by the Central Public Health Laboratory of the Enteropathogen Network. Species, serotypes, and resistance profiles were identified following standardized protocols. Data were processed in Microsoft Excel® and analyzed using descriptive statistics. Results: Pediatric cases predominated (69.8%). Shigella sonnei (67.2%) and Shigella flexneri (32.8%) were identified. Among 155 strains of S. flexneri, the most frequent serotype was 2a (63.2%). Observed resistance was trimethoprim-sulfamethoxazole 62.6%, ampicillin 39.7%, and azithromycin 13.4%. Intermediate resistance was found to ciprofloxacin 19.4% and azithromycin 21.3%. Conclusions: The study demonstrated the prevalence of S. sonnei and serotype 2a of S. flexneri, along with resistance patterns that compromise commonly used antibiotics. These findings reinforce the need to maintain active laboratory surveillance, update therapeutic guidelines, and strengthen control strategies against resistant strains, with direct impact on public health and clinical management of shigellosis in Paraguay.
- 30 April 2026
- Published by Sociedad Paraguaya de Pediatria in Pediatría (Asunción)
- Vol. 53 (1) , 5-14
Open AccessDistribución de especies, serotipos y resistencia antimicrobiana de Shigella spp. en pacientes del área metropolitana de Paraguay (2019-2025)
Introduction: Shigellosis is an acute infection caused by bacteria of the genus Shigella, with high prevalence in pediatric populations. Surveillance allows the identification of serotypes and resistance patterns, improving clinical and epidemiological management. Objective: To determine the distribution of species, serotypes, and antimicrobial resistance of Shigella spp. in the metropolitan area of Paraguay (2019–2025). Methods: A cross-sectional descriptive observational study was conducted on 610 clinical bacterial isolates received by the Central Public Health Laboratory of the Enteropathogen Network. Species, serotypes, and resistance profiles were identified following standardized protocols. Data were processed in Microsoft Excel® and analyzed using descriptive statistics. Results: Pediatric cases predominated (69.8%). Shigella sonnei (67.2%) and Shigella flexneri (32.8%) were identified. Among 155 strains of S. flexneri, the most frequent serotype was 2a (63.2%). Observed resistance was trimethoprim-sulfamethoxazole 62.6%, ampicillin 39.7%, and azithromycin 13.4%. Intermediate resistance was found to ciprofloxacin 19.4% and azithromycin 21.3%. Conclusions: The study demonstrated the prevalence of S. sonnei and serotype 2a of S. flexneri, along with resistance patterns that compromise commonly used antibiotics. These findings reinforce the need to maintain active laboratory surveillance, update therapeutic guidelines, and strengthen control strategies against resistant strains, with direct impact on public health and clinical management of shigellosis in Paraguay.